Overview
Thymic-renal-anal-lung dysplasia (TRALD), also known as FATAL syndrome (Facio-Tracheo-Anal-Lung dysplasia) or thymic-renal-anal-lung dysplasia syndrome, is an extremely rare and typically lethal congenital malformation syndrome. The condition is characterized by the combined developmental abnormalities (dysplasia) of multiple organ systems, specifically the thymus, kidneys, anus, and lungs. Affected infants present with thymic aplasia or hypoplasia leading to severe immunodeficiency, renal dysplasia or agenesis causing kidney malfunction, anal atresia (imperforate anus), and pulmonary hypoplasia or lung dysplasia resulting in severe respiratory insufficiency. Additional features that have been reported in some cases include intrauterine growth restriction, facial dysmorphism, and tracheal anomalies. The condition typically presents at birth or is detected prenatally, and affected neonates generally have a very poor prognosis, with most cases being lethal in the neonatal period due to the severity of the combined organ malformations, particularly respiratory failure from pulmonary hypoplasia. The underlying genetic cause remains incompletely understood, though familial recurrence in some cases has suggested a genetic basis. Given the extreme rarity and severity of this condition, treatment is largely supportive and palliative, with no curative therapy currently available. Management focuses on addressing individual organ system complications as they arise.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Thymic-renal-anal-lung dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Thymic-renal-anal-lung dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Thymic-renal-anal-lung dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Thymic-renal-anal-lung dysplasia.
Community
No community posts yet. Be the first to share your experience with Thymic-renal-anal-lung dysplasia.
Start the conversation →Latest news about Thymic-renal-anal-lung dysplasia
No recent news articles for Thymic-renal-anal-lung dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Thymic-renal-anal-lung dysplasia
What is Thymic-renal-anal-lung dysplasia?
Thymic-renal-anal-lung dysplasia (TRALD), also known as FATAL syndrome (Facio-Tracheo-Anal-Lung dysplasia) or thymic-renal-anal-lung dysplasia syndrome, is an extremely rare and typically lethal congenital malformation syndrome. The condition is characterized by the combined developmental abnormalities (dysplasia) of multiple organ systems, specifically the thymus, kidneys, anus, and lungs. Affected infants present with thymic aplasia or hypoplasia leading to severe immunodeficiency, renal dysplasia or agenesis causing kidney malfunction, anal atresia (imperforate anus), and pulmonary hypoplas
How is Thymic-renal-anal-lung dysplasia inherited?
Thymic-renal-anal-lung dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Thymic-renal-anal-lung dysplasia typically begin?
Typical onset of Thymic-renal-anal-lung dysplasia is neonatal. Age of onset can vary across affected individuals.